Annual Current Liabilities
$20.12 M
+$223.00 K+1.12%
December 31, 2023
Summary
- As of February 7, 2025, ATAI annual total current liabilities is $20.12 million, with the most recent change of +$223.00 thousand (+1.12%) on December 31, 2023.
- During the last 3 years, ATAI annual current liabilities has risen by +$7.82 million (+63.60%).
- ATAI annual current liabilities is now -7.34% below its all-time high of $21.71 million, reached on December 1, 2017.
Performance
ATAI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$19.64 M
+$2.00 M+11.33%
September 30, 2024
Summary
- As of February 7, 2025, ATAI quarterly total current liabilities is $19.64 million, with the most recent change of +$2.00 million (+11.33%) on September 30, 2024.
- Over the past year, ATAI quarterly current liabilities has dropped by -$52.00 thousand (-0.26%).
- ATAI quarterly current liabilities is now -87.04% below its all-time high of $151.58 million, reached on June 1, 2018.
Performance
ATAI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ATAI Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.1% | -0.3% |
3 y3 years | +63.6% | -11.1% |
5 y5 years | +600.9% | -11.1% |
ATAI Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -3.9% | +1.1% | -24.2% | +30.8% |
5 y | 5-year | -3.9% | +1152.0% | -50.3% | +59.7% |
alltime | all time | -7.3% | +1152.0% | -87.0% | +601.3% |
Atai Life Sciences NV Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $19.64 M(+11.3%) |
Jun 2024 | - | $17.64 M(+17.5%) |
Mar 2024 | - | $15.01 M(-25.4%) |
Dec 2023 | $20.12 M(+1.1%) | $20.12 M(+2.2%) |
Sep 2023 | - | $19.70 M(+9.9%) |
Jun 2023 | - | $17.93 M(-10.2%) |
Mar 2023 | - | $19.95 M(+0.3%) |
Dec 2022 | $19.90 M(-5.0%) | $19.90 M(-23.2%) |
Sep 2022 | - | $25.91 M(+18.0%) |
Jun 2022 | - | $21.96 M(-0.6%) |
Mar 2022 | - | $22.09 M(+5.5%) |
Dec 2021 | $20.93 M(+70.2%) | $20.93 M(+36.7%) |
Sep 2021 | - | $15.32 M(+8.0%) |
Jun 2021 | - | $14.19 M(-25.6%) |
Mar 2021 | - | $19.06 M(+55.0%) |
Dec 2020 | $12.30 M(+665.3%) | $12.30 M(-68.6%) |
Sep 2020 | - | $39.16 M(+6.4%) |
Jun 2020 | - | $36.82 M(-6.8%) |
Mar 2020 | - | $39.52 M(+4.4%) |
Dec 2019 | $1.61 M(-44.0%) | - |
Dec 2019 | - | $37.85 M(-9.1%) |
Sep 2019 | - | $41.65 M(+1386.9%) |
Jun 2019 | - | $2.80 M(-26.1%) |
Mar 2019 | - | $3.79 M(+32.1%) |
Dec 2018 | $2.87 M(-86.8%) | $2.87 M(-41.6%) |
Sep 2018 | - | $4.92 M(-96.8%) |
Jun 2018 | - | $151.58 M(+320.6%) |
Mar 2018 | - | $36.04 M(+146.7%) |
Dec 2017 | $21.71 M(+45.2%) | - |
Sep 2017 | - | $14.61 M(+21.7%) |
Jun 2017 | - | $12.00 M(-19.7%) |
Mar 2017 | $14.95 M(+30.0%) | $14.95 M(-20.5%) |
Dec 2016 | - | $18.80 M(+12.3%) |
Sep 2016 | - | $16.74 M(+60.4%) |
Jun 2016 | - | $10.44 M(-9.2%) |
Mar 2016 | $11.50 M | $11.50 M(-29.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | - | $16.36 M(+12.3%) |
Sep 2015 | - | $14.56 M(+30.4%) |
Jun 2015 | - | $11.17 M(-9.0%) |
Mar 2015 | $12.27 M(-1.3%) | $12.27 M(-10.2%) |
Dec 2014 | - | $13.66 M(-28.2%) |
Sep 2014 | - | $19.04 M(-13.7%) |
Jun 2014 | - | $22.06 M(+77.4%) |
Mar 2014 | $12.43 M(-2.9%) | $12.43 M(-34.9%) |
Dec 2013 | - | $19.09 M(+68.7%) |
Sep 2013 | - | $11.31 M(-29.2%) |
Jun 2013 | - | $15.97 M(+24.7%) |
Mar 2013 | $12.80 M(-11.2%) | $12.80 M(-18.1%) |
Dec 2012 | - | $15.64 M(+2.5%) |
Sep 2012 | - | $15.25 M(+24.2%) |
Jun 2012 | - | $12.28 M(-14.8%) |
Mar 2012 | $14.42 M(+40.4%) | $14.42 M(-7.6%) |
Dec 2011 | - | $15.61 M(+27.4%) |
Sep 2011 | - | $12.25 M(-39.3%) |
Jun 2011 | - | $20.18 M(+96.5%) |
Mar 2011 | $10.27 M(-10.3%) | $10.27 M(-7.8%) |
Jun 2010 | - | $11.14 M(-2.7%) |
Mar 2010 | $11.44 M(-8.3%) | $11.44 M(-10.4%) |
Dec 2009 | - | $12.78 M(+12.2%) |
Sep 2009 | - | $11.39 M(+4.3%) |
Jun 2009 | - | $10.92 M(-12.5%) |
Mar 2009 | $12.48 M(+31.3%) | $12.48 M(+28.8%) |
Dec 2008 | - | $9.69 M(-19.8%) |
Sep 2008 | - | $12.08 M(+39.3%) |
Jun 2008 | - | $8.67 M(-8.7%) |
Mar 2008 | $9.50 M(+60.8%) | $9.50 M(-8.1%) |
Dec 2007 | - | $10.34 M(+30.7%) |
Sep 2007 | - | $7.91 M(+33.8%) |
Mar 2007 | $5.91 M(-12.3%) | $5.91 M |
Mar 2006 | $6.74 M(-51.0%) | - |
Mar 2004 | $13.74 M(+53.3%) | - |
Dec 2003 | $8.96 M | - |
FAQ
- What is Atai Life Sciences NV annual total current liabilities?
- What is the all time high annual current liabilities for Atai Life Sciences NV?
- What is Atai Life Sciences NV annual current liabilities year-on-year change?
- What is Atai Life Sciences NV quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Atai Life Sciences NV?
- What is Atai Life Sciences NV quarterly current liabilities year-on-year change?
What is Atai Life Sciences NV annual total current liabilities?
The current annual current liabilities of ATAI is $20.12 M
What is the all time high annual current liabilities for Atai Life Sciences NV?
Atai Life Sciences NV all-time high annual total current liabilities is $21.71 M
What is Atai Life Sciences NV annual current liabilities year-on-year change?
Over the past year, ATAI annual total current liabilities has changed by +$223.00 K (+1.12%)
What is Atai Life Sciences NV quarterly total current liabilities?
The current quarterly current liabilities of ATAI is $19.64 M
What is the all time high quarterly current liabilities for Atai Life Sciences NV?
Atai Life Sciences NV all-time high quarterly total current liabilities is $151.58 M
What is Atai Life Sciences NV quarterly current liabilities year-on-year change?
Over the past year, ATAI quarterly total current liabilities has changed by -$52.00 K (-0.26%)